Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease

Abstract Quantifying variation in the ability to fight infection among free-living hosts is challenging and often constrained to one or a few measures of immune activity. While such measures are typically taken to reflect host resistance, they can also be shaped by pathogen effects, for example, if...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daisy E. Gates, Molly Staley, Luc Tardy, Mathieu Giraudeau, Geoffrey E. Hill, Kevin J. McGraw, Camille Bonneaud
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/4acd99ab8a1f491aad188848dc670c18
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4acd99ab8a1f491aad188848dc670c18
record_format dspace
spelling oai:doaj.org-article:4acd99ab8a1f491aad188848dc670c182021-12-02T14:26:20ZLevels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease10.1038/s41598-021-87464-92045-2322https://doaj.org/article/4acd99ab8a1f491aad188848dc670c182021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87464-9https://doaj.org/toc/2045-2322Abstract Quantifying variation in the ability to fight infection among free-living hosts is challenging and often constrained to one or a few measures of immune activity. While such measures are typically taken to reflect host resistance, they can also be shaped by pathogen effects, for example, if more virulent strains trigger more robust immune responses. Here, we test the extent to which pathogen-specific antibody levels, a commonly used measure of immunocompetence, reflect variation in host resistance versus pathogen virulence, and whether these antibodies effectively clear infection. House finches (Haemorhous mexicanus) from resistant and susceptible populations were inoculated with > 50 isolates of their novel Mycoplasma gallisepticum pathogen collected over a 20-year period during which virulence increased. Serum antibody levels were higher in finches from resistant populations and increased with year of pathogen sampling. Higher antibody levels, however, did not subsequently give rise to greater reductions in pathogen load. Our results show that antibody responses can be shaped by levels of host resistance and pathogen virulence, and do not necessarily signal immune clearance ability. While the generality of this novel finding remains unclear, particularly outside of mycoplasmas, it cautions against using antibody levels as implicit proxies for immunocompetence and/or host resistance.Daisy E. GatesMolly StaleyLuc TardyMathieu GiraudeauGeoffrey E. HillKevin J. McGrawCamille BonneaudNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Daisy E. Gates
Molly Staley
Luc Tardy
Mathieu Giraudeau
Geoffrey E. Hill
Kevin J. McGraw
Camille Bonneaud
Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
description Abstract Quantifying variation in the ability to fight infection among free-living hosts is challenging and often constrained to one or a few measures of immune activity. While such measures are typically taken to reflect host resistance, they can also be shaped by pathogen effects, for example, if more virulent strains trigger more robust immune responses. Here, we test the extent to which pathogen-specific antibody levels, a commonly used measure of immunocompetence, reflect variation in host resistance versus pathogen virulence, and whether these antibodies effectively clear infection. House finches (Haemorhous mexicanus) from resistant and susceptible populations were inoculated with > 50 isolates of their novel Mycoplasma gallisepticum pathogen collected over a 20-year period during which virulence increased. Serum antibody levels were higher in finches from resistant populations and increased with year of pathogen sampling. Higher antibody levels, however, did not subsequently give rise to greater reductions in pathogen load. Our results show that antibody responses can be shaped by levels of host resistance and pathogen virulence, and do not necessarily signal immune clearance ability. While the generality of this novel finding remains unclear, particularly outside of mycoplasmas, it cautions against using antibody levels as implicit proxies for immunocompetence and/or host resistance.
format article
author Daisy E. Gates
Molly Staley
Luc Tardy
Mathieu Giraudeau
Geoffrey E. Hill
Kevin J. McGraw
Camille Bonneaud
author_facet Daisy E. Gates
Molly Staley
Luc Tardy
Mathieu Giraudeau
Geoffrey E. Hill
Kevin J. McGraw
Camille Bonneaud
author_sort Daisy E. Gates
title Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
title_short Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
title_full Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
title_fullStr Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
title_full_unstemmed Levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
title_sort levels of pathogen virulence and host resistance both shape the antibody response to an emerging bacterial disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/4acd99ab8a1f491aad188848dc670c18
work_keys_str_mv AT daisyegates levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
AT mollystaley levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
AT luctardy levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
AT mathieugiraudeau levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
AT geoffreyehill levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
AT kevinjmcgraw levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
AT camillebonneaud levelsofpathogenvirulenceandhostresistancebothshapetheantibodyresponsetoanemergingbacterialdisease
_version_ 1718391365877891072